Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Broad opportunities for research funding related to COVID-19

Date added:

BARDA is looking to help the development of products to diagnose, prevent or treat novel coronavirus infections. (BARDA will only accept submissions related to the SARS-CoV-2 virus or the COVID-19 disease until further notice.)

Amount
Unlimited
Agency or Funder
Biomedical Advanced Research and Development Authority (BARDA)
Eligibility (if available)

Single entities or teams from private sector organizations, Government laboratories, and academic institutions.

Date application deadline

COVID-19's impact on reproduction, pregnancy, and foetal and neonatal health

Date added:

Exploratory, basic, and clinical research should address but is not limited to COVID-19 in patients at different pregnancy stages, and its impact on ongoing fertility care, gametes and embryos from patients exposed to SARS-CoV-2.

Amount
Up to €25,000
Agency or Funder
Ferring Pharmaceuticals
Foreign participation? (where known)
Yes
Date application deadline

Call for funding to research COVID-19

Date added:

The biology of the virus and its transmission, animal and environmental research on the origin of the virus, including control measures at the human-animal interface, epidemiological studies, clinical characterization and clinical management, infe

Amount
€10M
Agency or Funder
Federal Ministry of Education and Research
Eligibility (if available)

Must comply with uniform standards for quality assurance of biomaterial banks, patient registers,
IT networking, animal studies, including ARRIVE guidelines

Foreign participation? (where known)
No
Date application deadline

Competitive revision and administrative supplements to clinical and translational awardees

Date added:

Additional support for current Clinical and Translational Science Award (CTSA) award recipients for digital health platforms, planning of COVID-19 trials and clinical study data.

Amount
Not limited
Agency or Funder
National Center for Advancing Translational Sciences
Eligibility (if available)

Clinical and Translational Science Award (CTSA) award recipients

Foreign participation? (where known)
No
Date application deadline

Community interventions for vulnerable and disadvantaged groups

Date added:

Projects should address the consequences of the pandemic in NIH-designated health disparity populations and vulnerable groups.

Amount
$500,000 of yearly costs per project
Agency or Funder
National Institutes of Health
Eligibility (if available)

Higher education institutions, nonprofits, for-profit organisations, local and federal governments. Applicants' institutions with foreign components are accepted.

Foreign participation? (where known)
Yes
Date application deadline

Funding for Spanish universities

Date added:

Research must aim to minimise the impact of the COVID-19 crisis on healthcare, education, or society.

Amount
€8.5 M
Agency or Funder
Crue Spanish Universities, CSIC, Santander
Eligibility (if available)

Universities and research centres based in Spain and affiliated with the fund.

Foreign participation? (where known)
No
Date application deadline

Calling all Lithuanian researchers

Date added:

Use open-access data to produce recommendations on how to minimise or halt the spread of the coronavirus.

Amount
€700,000
Agency or Funder
Research Council of Lithuania
Eligibility (if available)

Lithuanian institution included in the Register of Education and Science Institutions or the Academy of Science.

Foreign participation? (where known)
No
Date application deadline

Travel and subsistence funding to support Low- and Middle-Income Country engagement during the COVID-19 outbreak

Date added:

Travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries.

Agency or Funder
NIHR
Date application deadline

Empowering life sciences with innovative technologies to fight COVID-19

Date added:

Projects should include areas from at least one core technologies – microfluidics;
biophotonics and waves; image analysis and Big Data – and one end-use application.

Amount
€15,000 - €30,000
Agency or Funder
DIM ELICIT
Eligibility (if available)

Research teams from the Ile de France region

Foreign participation? (where known)
No
Date application deadline

Short-term projects addressing the COVID-19 outbreak in low- and middle-income countries

Date added:

UK and LMIC-based research organisations are invited to address LMIC COVID-19 response and recovery or gather critical data and resources for future research use.

Amount
80% of the full economic cost for UK applicants, 100% for LMIC applicants
Agency or Funder
UKRI
Eligibility (if available)

Any UK researchers eligible for UKRI funding and LMIC-based organisations

Foreign participation? (where known)
Yes
Date application deadline

Clinical trials for at-risk elderly people

Date added:

Project should focus on multi-site clinical trials to address ageing-related issues such as reducing transmission, risk, morbidity, mortality, severity, or complications of COVID-19.

Amount
Not limited
Agency or Funder
National Institutes of Health and National Institute on Aging
Eligibility (if available)

Higher education institutions, nonprofits, for-profit organisations, local and federal governments, non-U.S entities, non-U.S. components of U.S. organisations

Foreign participation? (where known)
Yes
Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added:

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline

NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak

Date added:

Research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019).

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID
Eligibility (if available)

Grantees currently supported by active NIH (National Institute of Allergy and Infectius Diseases) funding

Date application deadline

Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Date added:

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Existing NIAID grantholders

Date application deadline

Rapid response call for UK-led research into COVID-19

Date added:

UKRI calls for projects with potential to deliver a significant contribution to the understanding, prevention or management of the COVID-19 outbreak within 12 months.

Amount
UK - 80% of full economic costs. Overseas - 100% direct costs only
Agency or Funder
UK Research and Innovation and the Department of Health and Social Care
Eligibility (if available)

Principal investigator must be hosted by an institution eligible for UKRI funding.

Foreign participation? (where known)
Yes
Date application deadline

Existing calls welcome proposals to develop medical countermeasures against SARS-CoV-2/COVID-19

Date added:

NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Date application deadline